While an adverse event reported in Intellia’s gene therapy trial was a “non-concern” for analysts, it follows a handful of ...

Looking for a biopharma job in New York? Check out the BioSpace list of seven companies hiring life sciences professionals ...

Patritumab deruxtecan was unable to significantly improve overall survival in patients with locally advanced or metastatic ...

Teos expects to absorb nearly $25 million in one-time costs for severance and termination payments. The biotech had 173 ...

The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.